The molecular epidemiology of tuberculosis. Recent trends in a low burden country

Danish Medical Bulletin

Volumn 52, Issue 4, 2005, Pages 143-159

  Lillebæk, Troels ^a,b  

^a STATENS SERUM INSTITUT   (Denmark)

^b NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; BACTERIAL DNA; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CLUSTER ANALYSIS; DNA FINGERPRINTING; HUMAN; IMMIGRATION; INCIDENCE; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; REINFECTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; STRAIN DIFFERENCE; TUBERCULOSIS; TUBERCULOSIS CONTROL;

DENMARK; EMIGRATION AND IMMIGRATION; EPIDEMIOLOGY, MOLECULAR; HUMANS; INCIDENCE; MYCOBACTERIUM TUBERCULOSIS; REFUGEES; SOMALIA; TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 33646142998     PISSN: 16039629     EISSN: 16039629     Source Type: Journal    
DOI: None     Document Type: Review

References (186)

1. Lillebaek T, Poulsen S, Kok-Jensen A. Tuberculosis treatment in Denmark: treatment outcome for all Danish patients in 1992. Int J Tuberc Lung Dis 1999;3(7):603-612.
2. Lillebaek T, Andersen AB AB, Bauer J, Dirksen A, Glismann S, de Haas P et al. Risk of Mycobacterium tuberculosis Transmission in a Low-Incidence Country Due to Immigration from High-Incidence Areas. J Clin Microbiol 2001;39(3):855-861.
3. Lillebaek T, Dirksen A, Baess I, Strunge B, Thomsen VO, Andersen AB. Molecular Evidence of Endogenous Reactivation of Mycobacterium tuberculosis after 33 Years of Latent Infection. J Infect Dis 2002;185(3): 401-404.
4. Lillebaek T, Andersen AB, Dirksen A, Smith E, Skovgaard LT, Kok-Jensen A. Persistent high incidence of tuberculosis in immigrants in a low incidence country. Emerg Infect Dis 2002;8(7):679-684.
5. Lillebaek T, Dirksen A, Vynnycky E, Baess I, Thomsen V, Andersen AB. Stability of DNA fingerprint patterns and evidence of Mycobacterium tuberculosis reactivation occuring decades after the initial infection. J Infect Dis 2003;188(7):1032-1039.
6. Lillebaek T, Andersen AB, Dirksen A, Glynn JR, Kremer K. Mycobacterium tuberculosis Beijing genotype. Emerg Infect Dis 2003;9(12):1553-1557.
7. Lillebaek T, Dirksen A, Kok-Jensen A, Andersen AB. Dominant Mycobacterium tuberculosis strain emerging rapidly in Denmark. Int J Tuberc Lung Dis 2003;8(8):1001-1006.
8. Moore JP, Dragic T. HIV. See a pocket; block it. Nature 1999;401(6755): 759.
9. Raviglione MC. The TB epidemic from 1992 to 2002. Tuberculosis (Edinb) 2003;83(1-3):4-14.
10. Groth-Petersen E, Knudsen J, Wilbek E. Epidemiological basis of tuberculosis eradication in an advanced country. Bull World Health Organ 1959;21:5-49.
11. Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet 2003;362(9387):887-899.
12. Gomez JE, McKinney JD. M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb) 2004;84(1-2):29-44.
13. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 1991;72(1):1-6.
14. Zumla A, Mwaba P, Squire SB, Grange JM. The tuberculosis pandemic - which way now? J Infect 1999;38(2):74-79.
15. Moszynski P. TB epidemic is still growing in Africa and in eastern Europe. BMJ 2003;326(7391):676.
16. Shilova MV, Dye C. The resurgence of tuberculosis in Russia. Philos Trans R Soc Lond B Biol Sci 2001;356(1411):1069-1075.
17. EuroTB and the national coordinators for tuberculosis surveillance in the WHO European Region. Report om tuberculosis cases reported in 2001. Euro TB staff, editor. 1-119. 2003. Saint-Maurice, EuroTB.
18. Barnes PF, Bloch AB, Davidson PT, Snider DE, Jr. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1991;324(23):1644-1650.
19. Elzinga G, Raviglione MC, Maher D. Scale up: meeting targets in global tuberculosis control. Lancet 2004;363(9411):814-819.
20. Sonnenberg P, Glynn JR, Fielding K, Murray J, Godfrey-Faussett P, Shearer S. HIV and pulmonary tuberculosis: the impact goes beyond those infected with HIV. AIDS 2004;18(4):657-662.
21. World Health Organisation document. WHO tuberculosis programme: framework for effective tuberculosis control. WHO/TB/94.1, 1-7. 1994. Geneva, Switzerland, WHO.
22. Clancy L, Rieder HL, Enarson DA, Spinaci S. Tuberculosis elimination in the countries of Europe and other industrialized countries. Eur Respir J 1991;4(10):1288-1295.
23. Broekmans J, Migliori GB, Rieder HL, Leese J, Ruutu P, Loddenkemper R et al. European framework for tuberculosis control and elimination in countries with a low incidence. Eur Respir J 2002;19:765-775.
24. Lindhardt M. Tuberculosis statistics. In: The national association for the fight against tuberculosis, editor. The fight against tuberculosis in Denmark. Copenhagen: Nyt nordisk forlag Arnold Busch, 1950: 113-133.
25. Raviglione MC, Sudre P, Rieder HL, Spinaci S, Kochi A. Secular trends of tuberculosis in western Europe. Bull World Health Organ 1993;71(3-4): 297-306.
26. WHO. DOTS expansion plan to stop TB in the WHO European Region 2002-2006. Danzon M, editor. ISBN 92 890 1367 2, 1-46. 2002. Copenhagen, World Health Organization.
27. Lillebaek T, Thomsen V. Bekymrende tendens i spredningen af tuberkulose blandt danske maend. Ugeskr Laeger 2004;5;167:388-91.
28. Poulsen S, Ronne T, Kok-Jensen A, Bauer JO, Miorner H. Tuberkuloseudviklingen i Danmark 1972-1996. Ugeskr Laeger 1999;161(23): 3452-3457.
29. Lange P, Mortensen J, Viskum K. Tuberculosis in a developed country. Acta Med Scand 1986;219(5):481-487.
30. Veen J, Raviglione M, Rieder HL, Migliori GB, Graf P, Grzemska M et al. Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform reporting by cohort analysis of treatment outcome in tuberculosis patients. Eur Respir J 1998;12(2):505-510.
31. Bhatti N, Law MR, Morris JK, Halliday R, Moore-Gillon J. Increasing incidence of tuberculosis in England and Wales: a study of the likely causes. BMJ 1995;310(6985):967-969.
32. Murray JF. The white plague: down and out, or up and coming? J. Burns Amberson lecture. Am Rev Respir Dis 1989;140(6):1788-1795.
33. Bhatti N, Law MR, Morris JK, Halliday R, Moore-Gillon J. Increasing incidence of tuberculosis in England and Wales: a study of the likely causes. BMJ 1995;310(6985):967-969.
34. Reichman LB. The U-shaped curve of concern. Am Rev Respir Dis 1991;144(4):741-742.
35. Schneider E, Castro KG. Tuberculosis trends in the United States, 1992-2001. Tuberculosis (Edinb) 2003;83(1-3):21-29.
36. Yang Z. Application of Restriction Fragment Length Polymorphism analysis of Mycobacterium tuberculosis in epidemiology and strain characterization. University of Copenhagen, 1994.
37. Bauer J. Molecular epidemiology studies of the Mycobacterium tuberculosis complex and the Mycobacterium avium complex. University of Copenhagen, 1999.
38. van Soolingen D. Molecular epidemiology of tuberculosis and other mycobacterial infections: main methodologies and achievements. J Intern Med 2001;249(1):1-26.
39. Barnes PF, Cave MD. Molecular epidemiology of tuberculosis. N Engl J Med 2003;349(12):1149-1156.
40. Godfrey-Faussett P. DNA fingerprinting: A powerful new tool for the study of tuberculosis. In: Davies PDO, editor. Clinical tuberculosis. London: Chapman & Hall Medical, 1994: 391-400.
41. Bifani PJ, Mathema B, Kurepina NE, Kreiswirth BN. Global dissemination of the Mycobacterium tuberculosis W-Beijing family strains. Trends Microbiol 2002;10(1):45-52.
42. van Embden JD, Cave MD, Crawford JT, Dale JW, Eisenach KD, Gicquel B et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993;31(2):406-409.
43. Heersma HF, Kremer K, van Embden JD. Computer analysis of IS6110 RFLP patterns of Mycobacterium tuberculosis. Methods Mol Biol 1998;101:395-422.
44. Heersma HF, Kremer K. Manual Bionumerics. 1st. ed. Bilthoven: Conserted action on new generation markers and techniques for the epidemiology and control of tuberculosis, 2001.
45. Glynn JR, Bauer J, de Boer AS, Borgdorff MW, Fine PE, Godfrey-Faussett P et al. Interpreting DNA fingerprint clusters of Mycobacterium tuberculosis. European Concerted Action on Molecular Epidemiology and Control of Tuberculosis. Int J Tuberc Lung Dis 1999;3(12):1055-1060.
46. Murray M, Alland D. Methodological problems in the molecular epidemiology of tuberculosis. Am J Epidemiol 2002;155(6):565-571.
47. Murray M. Sampling bias in the molecular epidemiology of tuberculosis. Emerg Infect Dis 2002;8(4):363-369.
48. Yang ZH, de Haas PE, van Soolingen D, van Embden JD, Andersen AB. Restriction fragment length polymorphism Mycobacterium tuberculosis strains isolated from Greenland during 1992: evidence of tuberculosis transmission between Greenland and Denmark. J Clin Microbiol 1994;32(12):3018-3025.
49. Cosma CL, Sherman DR, Ramakrishnan L. The secret fives of the pathogenic mycobacteria. Annu Rev Microbiol 2003;57:641-76.:641-676.
50. American Thoracic Society. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis 1990;142(3):725-735.
51. Rhoades ER, Ullrich HJ. How to establish a lasting relationship with your host: lessons learned from Mycobacterium, spp. Immunol Cell Biol 2000;78(4):301-310.
52. Lillebaek T, Kok-Jensen A, Viskum K. Bacillarity at autopsy in pulmonary tuberculosis: Mycobacterium tuberculosis is often disseminated. APMIS 2002;110:625-629.
53. Ellner JJ. Review: the immune response in human tuberculosis - implications for tuberculosis control. J Infect Dis 1997;176(5):1351-1359.
54. Saunders BM, Cooper AM. Restraining mycobacteria: role of granulomas in mycobacterial infections. Immunol Cell Biol 2000;78(4):334-341.
55. Manabe YC, Bishai WR. Latent Mycobacterium tuberculosis - persistence, patience, and winning by waiting. Nat Med 2000;6(12):1327-1329.
56. Sutherland I, Svandova E, Radhakrishna S. Alternative models for the development of tuberculosis disease following infection with tubercle bacilli. Bull Int Union Tuberc 1976;51(1):171-179.
57. Andersen AB. Mycobacterium tuberculosis proteins: Structure, function and immunological relevance. Copenhagen University, 2003.
58. Hernández-Pando R, Jeyanathan M, Mengistu G, Aguilar D, Orozco H, Harboe M et al. Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet 2000;356:2133-2138.
59. Vynnycky E, Fine PE. Lifetime risks, incubation period, and serial interval of tuberculosis. Am J Epidemiol 2000;152(3):247-263.
60. Vynnycky E, Fine PE. The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection. Epidemiol Infect 1997;119(2):183-201.
61. Smith P, Moss A. Epidemiology of tuberculosis. In: Bloom B, editor. Tuberculosis Pathogenesis, Protection, and Control. Washington, DC: ASM press, 1994: 48-51.
62. Stead WW. Pathogenesis of a first episode of chronic pulmonary tuberculosis in man: recrudescence of residuals of the primary infection or exogenous reinfection? Am Rev Respir Dis 1967;95(5):729-745.
63. Small PM, Shafer RW, Hopewell PC, Singh SP, Murphy MJ, Desmond E et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med 1993;328(16):1137-1144.
64. Warren R, Richardson M, van der Spuy G, Victor T, Sampson S, Beyers N et al. DNA fingerprinting and molecular epidemiology of tuberculosis: use and interpretation in an epidemic setting. Electrophoresis 1999;20(8):1807-1812.
65. Doveren RF, Keizer ST, Kremer K, van Soolingen D. [Connection between 2 tuberculosis outbreaks demonstrated after 8 years by DNA-fingerprinting of the causative mycobacteria]. Ned Tijdschr Geneeskd 1998;142(4):189-192.
66. Arend SM, van Soolingen D, Ottenhoff TH, van Dissel JT. Repeatedly negative tuberculin skin tests followed by active tuberculosis in an immunocompetent individual. Neth J Med 2001;58(2):76-81.
67. Baess I. Subdivision of M. tuberculosis by means of bacteriophages. With special reference to epidemiological studies. Acta Pathol Microbiol Scand 1969;76(3):464-474.
68. Baess I. A bacteriophage for subdividing the species M. tuberculosis. Am Rev Respir Dis 1966;93(4):622-623.
69. Baess I. Results of typing of M. tuberculosis with seven known and two adapted phages. Ann Sclavo 1975;17(4):563-567.
70. van Heiden PD. Molecular epidemiology of TB: challenging dogmas and asking new questions. IUBMB Life 2002;53(4-5):219-223.
71. Cole ST. Comparative and functional genomics of the Mycobacterium tuberculosis complex. Microbiology 2002;148(Pt 10):2919-2928.
72. Young DB. Ten years of research progress and what's to come. Tuberculosis (Edinb) 2003;83(1-3):77-81.
73. Mukamolova GV, Kaprelyants AS, Kell DB, Young M. Adoption of the transiently non-culturable state - a bacterial survival strategy? Adv Microb Physiol 2003;47:65-129:65-129.
74. Timm J, Post FA, Bekker LG, Walther GB, Wainwright HC, Manganelli R et al. Differential expression of iron-, carbon-, and oxygen-responsive mycobacterial genes in the lungs of chronically infected mice and tuberculosis patients. Proc Natl Acad Sci U S A 2003;100(24):14321-14326.
75. Stewart GR, Robertson BD, Young DB. Tuberculosis: a problem with persistence. Nat Rev Microbiol 2003;1(2):97-105.
76. Lambert ML, Hasker E, Van Deun A, Roberfroid D, Boelaert M, Van der SP. Recurrence in tuberculosis: relapse or reinfection? Lancet Infect Dis 2003;3(5):282-287.
77. Romeyn JA. Exogenous reinfection in tuberculosis. Am Rev Respir Dis 1970;101(6):923-927.
78. Canetti G, Sutherland I, Svandova E. Endogenous reactivation and exogenous reinfection. Their relative importance in the outbreak of nonprimary tuberculosis. Bull Int Union Tuberc 1972;47:122-143.
79. van Rie A, Warren R, Richardson M, Victor TC, Gie RP, Enarson DA et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N Engl J Med 1999;341(16):1174-1179.
80. de Viedma DG, Marin M, Hernangomez S, Diaz M, Ruiz Serrano MJ, Alcala L et al. Tuberculosis recurrences: reinfection plays a role in a population whose clinical/epidemiological characteristics do not favor reinfection. Arch Intern Med 2002;162 (16):1873-1879.
81. Caminero JA, Pena MJ, Campos-Herrero MI, Rodriguez JC, Afonso O, Martin C et al. Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease. Am J Respir Crit Care Med 2001;163(3 Pt 1):717-720.
82. de Boer AS, Borgdorff MW, Vynnycky E, Sebek MM, van Soolingen D. Exogenous re-infection as a cause of recurrent tuberculosis in a low-incidence area. Int J Tuberc Lung Dis 2003;7(2):145-152.
83. Kruuner A, Pehme L, Ghebremichael S, Koivula T, Hoffner SE, Mikelsaar M. Use of Molecular Techniques to Distinguish between Treatment Failure and Exogenous Reinfection with Mycobacterium tuberculosis. Clin Infect Dis 2002;35(2):146-155.
84. El Sahly HM, Wright JA, Soini H, Bui TT, Williams-Bouyer N, Escalante P et al. Recurrent tuberculosis in Houston, Texas: a population-based study. Int J Tuberc Lung Dis 2004;8(3):333-340.
85. Sonnenberg P, Murray J, Glynn JR, Shearer S, Kambashi B, Godfrey-Faussett P. HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers. Lancet 2001;358(9294):1687-1693.
86. Heldal E, Docker H, Caugant DA, Tverdal A. Pulmonary tuberculosis in Norwegian patients. The role of reactivation, re-infection and primary infection assessed by previous mass screening data and restriction fragment length polymorphism analysis. Int J Tuberc Lung Dis 2000;4(4): 300-307.
87. Styblo K, Enarson DA. Epidemiology of tuberculosis. 1 ed. The Hague: Royal Netherlands Tuberculosis Association, 1991.
88. Small PM, van Embden JDA. Molecular epidemiology of tuberculosis. In: Bloom B, editor. Tuberculosis pathohenesis, protection, and control. Washington, DC: ASM press, 1994: 569-582.
89. Alland D, Kalkut GE, Moss AR, McAdam RA, Hahn JA, Bosworth W et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994;330(24):1710-1716.
90. Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med 1994; 330(24):1703-1709.
91. Bauer J, Yang Z, Poulsen S, Andersen AB. Results from 5 years of nationwide DNA fingerprinting of Mycobacterium, tuberculosis complex isolates in a country with a low incidence of M. tuberculosis infection. J Clin Microbiol 1998;36(1):305-308.
92. Warren RM, van der Spuy GD, Richardson M, Beyers N, Borgdorff MW, Behr MA et al. Calculation of the stability of the IS6110 banding pattern in patients with persistent Mycobacterium tuberculosis disease. J Clin Microbiol 2002;40(5):1705-1708.
93. de Boer AS, Borgdorff MW, de Haas PE, Nagelkerke NJ, van Embden JD, van Soolingen D. Analysis of rate of change of IS6110 RFLP patterns of Mycobacterium tuberculosis based on serial patient isolates. J Infect Dis 1999;180(4):1238-1244.
94. Yeh RW, Ponce dL, Agasino CB, Hahn JA, Daley CL, Hopewell PC et al. Stability of Mycobacterium tuberculosis DNA genotypes. J Infect Dis 1998;177(4):1107-1111.
95. Braden CR, Templeton GL, Cave MD, Valway S, Onorato IM, Castro KG et al. Interpretation of restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates from a state with a large rural population. J Infect Dis 1997;175(6):1446-1452.
96. Yang ZH, de Haas PE, Wachmann CH, van Soolingen D, van Embden JD, Andersen AB. Molecular epidemiology of tuberculosis in Denmark in 1992. J Clin Microbiol 1995;33(8):2077-2081.
97. Koch R. Die aetiologie der tuberculose. Berliner klinische wochenschrift 1882;15:221-221.
98. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999;282(7):677-686.
99. Kok-Jensen A, Pedersen J, Taudorf E, Viskum K. Det nationale tuberkulose program og forslag til klinisk håndtering af TB. Den Almindelige Danske Lægeforening, editor. 11, 1-20. 2000. København, Dansk Lungemedicinsk Selskab.
100. Aoki M. Surveillance of tuberculosis in low prevalence countries where tuberculosis is in decline. Bull Int Union Tuberc Lung Dis 1991;66(4): 201-202.
101. Geng E, Kreiswirth B, Driver C, Li J, Burzynski J, DellaLatta P et al. Changes in the transmission of tuberculosis in New York City from 1990 to 1999. N Engl J Med 2002;346(19):1453-1458.
102. Cohn DL. Treatment of latent tuberculosis infection: renewed opportunity for tuberculosis control. Clin Infect Dis 2000;31(1):120-124.
103. Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 2000;161(4 Pt 2):S221-S247.
104. Comstock GW, Baum C, Snider DE, Jr. Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies. Am Rev Respir Dis 1979;119(5):827-830.
105. Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P. Comparison of a New Specific Blood Test and the Skin Test in Tuberculosis Contacts. Am J Respir Crit Care Med 2004;.
106. Grange JM, Zumla A. Paradox of the global emergency of tuberculosis. Lancet 1999;353(9157):996.
107. Rieder HL. Epidemiology of tuberculosis in Europe. Eur Respir J Suppl 1995;20:620s-632s.
108. Talbot EA, Moore M, McCray E, Binkin NJ. Tuberculosis among foreign-born persons in the United States, 1993-1998. JAMA 2000;284 (22):2894-2900.
109. Rieder HL, Zellweger JP, Raviglione MC, Keizer ST, Migliori GB. Tuberculosis control in Europe and international migration. Eur Respir J 1994;7(8):1545-1553.
110. EuroTB and the national coordinators for tuberculosis surveillance in the WHO European Region. Report on tuberculosis cases notified in 1997. In: Schwoebel V, Antoine D, Veen J, Jean F, editors. Surveillance of tuberculosis in Europe. Saint-Maurice: EuroTB, 1999: 7-95.
111. Farah MG, Tverdal A, Selmer R, Heldal E, Bjune G. Tuberculosis in Norway by country of birth, 1986-1999. Int J Tuberc Lung Dis 2003;7 (3):232-235.
112. Helbling P, Medinger C, Altpeter E, Raeber PA, Beeli D, Zellweger JP. Outcome of treatment of pulmonary tuberculosis in Switzerland in 1996. Swiss Med Wkly 2002;132(35-36):517-522.
113. EuroTB and the national coordinators for tuberculosis surveillance in the WHO European Region. Report on tuberculosis cases notified in 2000. EuroTB staff, editor. 1-120. 2003. Saint-Maurice, EuroTB.
114. Wolleswinkel v, Nagelkerke NJ, Broekmans JF, Borgdorff MW. The impact of immigration on the elimination of tuberculosis in The Netherlands: a model based approach. Int J Tuberc Lung Dis 2002;6(2):130-136.
115. Cantwell MF, Snider DE, Jr., Cauthen GM, Onorato IM. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA 1994;272(7):535-539.
116. Wilcke JT, Poulsen S, Askgaard DS, Enevoldsen HK, Ronne T, Kok-Jensen A. Tuberculosis in a cohort of Vietnamese refugees after arrival in Denmark 1979-1982. Int J Tuberc Lung Dis 1998;2(3):219-224.
117. Steen TW, Farah MG, Johnsen NL, Johnsen H, Johnsen UL. [Extrapulmonary tuberculosis among Somali immigrants in Norway]. Tidsskr Nor Laegeforen 2003;%20;123(6):818-821.
118. Fritz MJ, Hedemark LL. Somali refugee health screening in Hennepin County. Minn Med 1998;81(4):43-47.
119. Kempainen R, Nelson K, Williams DN, Hedemark L. Mycobacterium tuberculosis disease in Somali immigrants in Minnesota. Chest 2001; 119(1):176-180.
120. Llewelyn M, Cropley I, Wilkinson RJ, Davidson RN. Tuberculosis diagnosed during pregnancy: a prospective study from London. Thorax 2000;55(2):129-132.
121. Wobeser WL, Yuan L, Naus M, Corey P, Edelson J, Heywood N et al. Expanding the epidemiologic profile: risk factors for active tuberculosis in people immigrating to Ontario. CMAJ 2000;163(7):823-828.
122. Borgdorff MW, Nagelkerke N, van Soolingen D, de Haas PE, Veen J, van Embden JD. Analysis of tuberculosis transmission between nationalities in the Netherlands in the period 1993-1995 using DNA fingerprinting. Am J Epidemiol 1998;147(2):187-195.
123. Shemko M, Yates M, Fang Z, Gibson A, Shetty N. Molecular epidemiology of Mycobacterium tuberculosis in patients of Somalian and white ethnic origin attending an inner London clinic. Int J Tuberc Lung Dis 2004;8(2):186-193.
124. Dahle UR, Sandven P, Heldal E, Mannsaaker T, Caugant DA. Deciphering an Outbreak of Drug-Resistant Mycobacterium tuberculosis. J Clin Microbiol 2003;41(1):67-72.
125. Peltola H, Mohamed ON, Kataja M, Salminen S, Tuittula T, Peltola TL et al. Risk of infection with Mycobacterium tuberculosis among children and mothers in Somalia. Clin Infect Dis 1994;18(1):106-111.
126. Heath-Brown N, Smith D, Roche M, Roche L, Hadley K, Kinnersley B et al. Somalia. In: Turner B, editor. The statemans yearbook: the politics, cultures and economics of the world. London: Sara Lloyd, 2000: 1413-1413.
127. World Health Organisation. Global tuberculosis control: WHO report 2000. WHO/CDS/TB/2000.275, 1-179. 2000. Geneva, Switzerland, WHO. Ref Type: Report.
128. Ormerod LP. Tuberculosis screening and prevention in new immigrants 1983-88. Respir Med 1990;84(4):269-271.
129. Zuber PL, McKenna MT, Binkin NJ, Onorato IM, Castro KG. Longterm risk of tuberculosis among foreign-born persons in the United States. JAMA 1997;278(4):304-307.
130. Rieder HL, Cauthen GM, Kelly GD, Bloch AB, Snider DE, Jr. Tuberculosis in the United States. JAMA 1989;262(3):385-389.
131. Enarson DA. Active tuberculosis in Indochinese refugees in British Columbia. Can Med Assoc J 1984;131(1):39-42.
132. Rapiti E, Fano V, Forastiere F, Agabiti N, Geraci S, Scano M et al. Determinants of tuberculosis in an immigrant population in Rome: a case-control study. Int J Tuberc Lung Dis 1998;2(6):479-483.
133. Andersen PH, Thomsen VO, Smith E. [Tuberculosis among children in Denmark, 1990-19991. Ugeskr Laeger 2001;163(48):6739-6742.
134. Andersen AB, Jarlov JO, Kok-Jensen A, Lillebaek T, Lundgren B, Rosdahl N et al. [Control of tuberculosis in Denmark]. Ugeskr Laeger 2000;162(16):2343.
135. Enarson DA. Strategies for the fight against tuberculosis. Pneumologie 1994;48(2):140-143.
136. Nur YA, Groen J, Elmi AM, Ott A, Osterhaus AD. Prevalence of serum antibodies against bloodborne and sexually transmitted agents in selected groups in Somalia. Epidemiol Infect 2000;124(1):137-141.
137. Scott DA, Corwin AL, Constantine NT, Omar MA, Guled A, Yusef M et al. Low prevalence of human immunodeficiency virus-1 (HIV-1), HIV-2, and human T cell lymphotropic virus-1 infection in Somalia. Am J Trop Med Hyg 1991;45(6):653-659.
138. Burans JP, Fox E, Omar MA, Farah AH, Abbass S, Yusef S et al. HIV infection surveillance in Mogadishu, Somalia. East Afr Med J 1990;67(7): 466-472.
139. Enarson D, Ashley MJ, Grzybowski S. Tuberculosis in immigrants to Canada. A study of present-day patterns in relation to immigration trends and birthplace. Am Rev Respir Dis 1979; 119(1):11-18.
140. Soborg C, Andersen AB, Madsen HO, Kok-Jensen A, Skinhoj P, Garred P. Natural resistance-associated macrophage protein 1 polymorphisms are associated with microscopy-positive tuberculosis. J Infect Dis 2002;186(4):517-521.
141. Soborg C, Madsen HO, Andersen AB, Lillebaek T, Kok-Jensen A, Garred P. Mannose-binding lectin polymorphisms in clinical tuberculosis. J Infect Dis 2003;188(5):777-782.
142. Vos A, Meima A, Verver S, Looman C, Bos V, Borgdorff MW et al. High incidence of pulmonary tuberculosis persists a decade after immigration, the Netherlands. Emerg Infect Dis 2004;10(4):736-739.
143. Enarson DA, Sjogren I, Grzybowski S. Incidence of tuberculosis among Scandinavian immigrants in Canada. Eur J Respir Dis 1980;61(3):139-142.
144. Migliori GB, Raviglione MC, Schaberg T, Davies PD, Zellweger JP, Grzemska M et al. Tuberculosis management in Europe. Task Force of the European Respiratory Society (ERS), the World Health Organisation (WHO) and the International Union against Tuberculosis and Lung Disease (IUATLD) Europe Region. Eur Respir J 1999;14(4):978-992.
145. Snider DE, Jr., Caras GJ. Isoniazid-associated hepatitis deaths: a review of available information. Am Rev Respir Dis 1992;145(2 Pt 1):494-497.
146. van Soolingen D, Borgdorff MW, de Haas PE, Sebek MM, Veen J, Dessens M et al. Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997. J Infect Dis 1999;180(3):726-736.
147. Borgdorff MW, Behr MA, Nagelkerke NJD, Hopewell PC, Small PM. Transmission of tuberculosis in San Francisco and its association with immigration and ethnicity. Int J Tuberc Lung Dis 2000;4(4):287-294.
148. Chin DP, DeRiemer K, Small PM, de Leon AP, Steinhart R, Schecter GF et al. Differences in contributing factors to tuberculosis incidence in U.S. -born and foreign-born persons. Am J Respir Crit Care Med 1998;158(6):1797-1803.
149. Cronin WA, Golub JE, Lathan MJ, Mukasa LN, Hooper N, Razeq JH et al. Molecular epidemiology of tuberculosis in a low- to moderate-incidence state: are contact investigations enough? Emerg Infect Dis 2002;8(11):1271-1279.
150. Dahle UR, Sandven P, Heldal E, Caugant DA. Molecular Epidemiology of Mycobacterium tuberculosis in Norway. J Clin Microbiol 2001;39(5):1802-1807.
151. Coker R. Compulsory screening of immigrants for tuberculosis and HIV. BMJ 2004;328(7435):298-300.
152. van Soolingen D, Qian L, de Haas PE, Douglas JT, Traore H, Portaels F et al. Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J Clin Microbiol 1995;33(12):3234-3238.
153. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997;35(4):907-914.
154. Bifani PJ, Mathema B, Liu Z, Moghazeh SL, Shopsin B, Tempalski B et al. Identification of a W variant outbreak of Mycobacterium tuberculosis via population-based molecular epidemiology. JAMA 1999;282(24): 2321-2327.
155. Kremer K, Glynn JR, Lillebaek T, Niemann S, Kurepina NE, Kreiswirth BN et al. Definition of the Beijing/W phylogenetic lineage of Mycobacterium tuberculosis on the basis of genetic markers. J Clin Microbiol 2004;[in press].
156. Bifani PJ, Plikaytis BB, Kapur V, Stockbauer K, Pan X, Lutfey ML et al. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 1996;275(6):452-457.
157. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D. Worldwide Occurrence of Beijing/W Strains of Myrobacterium tuberculosis: A Systematic Review. Emerg Infect Dis 2002;8(8):843-849.
158. Tracevska T, Jansone I, Baumanis V, Marga O, Lillebaek T. Prevalence of Beijing genotype in Latvian multi-drug resistant Mycobacterium tuberculosis isolates. Int J Tuberc Lung Dis 2003;7(11):1097-1103.
159. Anh DD, Borgdorff MW, Van LN, Lan NT, van Gorkom T, Kremer K et al. Mycobacterium tuberculosis Beijing genotype emerging in Vietnam. Emerg Infect Dis 2000;6(3):302-305.
160. Agerton TB, Valway SE, Blinkhorn RJ, Shilkret KL, Reves R, Schluter WW et al. Spread of strain W, a highly drug-resistant strain of Mycobacterium tuberculosis, across the United States. Clin Infect Dis 1999;29 (1):85-92.
161. Kruuner A, Hoffner SE, Sillastu H, Danilovits M, Levina K, Svenson SB et al. Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol 2001;39(9):3339-3345.
162. Pfyffer GE, Strassle A, van Gorkum T, Portaels F, Rigouts L, Mathieu C et al. Multidrug-resistant tuberculosis in prison inmates, Azerbaijan. Emerg Infect Dis 2001;7(5):855-861.
163. van Crevel R, Nelwan RH, de Lenne W, Veeraragu Y, van der Zanden AG, Amin Z et al. Mycobacterium tuberculosis Beijing genotype strains associated with febrile response to treatment. Emerg Infect Dis 2001;7 (5):880-883.
164. Lopez B, Aguilar D, Orozco H, Burger M, Espitia C, Ritacco V et al. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol 2003;133(1):30-37.
165. Caminero JA, Pena MJ, Campos-Herrero MI, Rodriguez JC, Garcia I, Cabrera P et al. Epidemiological evidence of the spread of a Mycobacterium tuberculosis strain of the Beijing genotype on Gran Canaria Island. Am J Respir Crit Care Med 2001;164(7):1165-1170.
166. Mokrousov I, Narvskaya O, Otten T, Vyazovaya A, Limeschenko E, Steklova L et al. Phylogenetic reconstruction within Mycobacterium tuberculosis Beijing genotype in northwestern Russia. Res Microbiol 2002;153(10):629-637.
167. Kubin M, Lillebaek T, Polanecky V, Kozakova B, Svecova Z, Papikova E et al. Molecular epidemiology of tuberculosis among prisoners. Epidemiol Mikrobiol Imunol 2003;52:3-8.
168. Prodinger WM, Bunyaratvej P, Prachaktam R, Pavlic M. Mycobacterium tuberculosis isolates of Beijing genotype in Thailand. Emerg Infect Dis 2001;7(3):483-484.
169. Banu S, Gordon SV, Palmer S, Islam R, Ahmed S, Alam KM et al. Genotypic analysis of Mycobacterium tuberculosis in Bangladesh and prevalence of the Beijing strain. J Clin Microbiol 2004;42(2):674-682.
170. McNabb SJ, Braden CR, Navin TR. DNA fngerprinting of Mycobacterium tuberculosis: lessons learned and implications for the future. Emerg Infect Dis 2002;8(11):1314-1319.
171. Richardson M, van Lill SW, van der Spuy GD, Munch Z, Booysen CN, Beyers N et al. Historic and recent events contribute to the disease dynamics of Beijing-like Mycobacterium tuberculosis isolates in a high incidence region. Int J Tuberc Lung Dis 2002;6(11):1001-1011.
172. van Rie A, Warren RM, Beyers N, Gie RP, Classen CN, Richardson M et al. Transmission of a multidrug-resistant Mycobacterium tuberculosis strain resembling "strain W" among noninstitutionalized, human immunodeficiency virus-seronegative patients. J Infect Dis 1999;180(5): 1608-1615.
173. Bruchfeld J, Aderaye G, Palme IB, Bjorvatn B, Ghebremichael S, Hoffner S et al. Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates from Ethiopian pulmonary tuberculosis patients with and without human immunodeficiency virus infection. J Clin Microbiol 2002;40(5):1636-1643.
174. Hermans PW, Messadi F, Guebrexabher H, van Soolingen D, de Haas PE, Heersma H et al. Analysis of the population structure of Mycobacterium tuberculosis in Ethiopia, Tunisia, and The Netherlands: usefulness of DNA typing for global tuberculosis epidemiology. J Infect Dis 1995;171(6):1504-1513.
175. Bhanu NV, van Soolingen D, van Embden JD, Dar L, Pandey RM, Seth P. Predominace of a novel Mycobacterium tuberculosis genotype in the Delhi region of India. Tuberculosis (Edinb) 2002;82(2-3):105-112.
176. Mistry NF, Iyer AM, D'souza DT, Taylor GM, Young DB, Antia NH. Spoligotyping of Mycobacterium tuberculosis isolates from multiple-drug-resistant tuberculosis patients from Bombay, India. J Clin Microbiol 2002;40(7):2677-2680.
177. Douglas JT, Qian L, Montoya J, Musser JM, van Embden JDA, van Soolingen D et al. Characterization of the Manilla family of Mycobacterium, tuberculosis. J Clin Microbiol 2003;41(6):2723-2726.
178. Puustinen K, Marjamaki M, Rastogi N, Sola C, Filliol I, Ruutu P et al. Characterization of Finnish Mycobacterium tuberculosis isolates by spoligotyping. J Clin Microbiol 2003;41(4):1525-1528.
179. Borgdorff MW, de Haas P, Kremer K, van Soolingen D. Mycobacterium
180. Bauer J, Kok-Jensen A, Faurschou P, Thuesen J, Taudorf E, Andersen AB. A prospective evaluation of the clinical value of nation-wide DNA fingerprinting of tuberculosis isolates in Denmark. Int J Tuberc Lung Dis 2000;4(4):295-299.
181. Control of tuberculosis in the United States. American Thoracic Society. Am Rev Respir Dis 1992;146(6):1623-1633.
182. Lillebaek T, Thomsen VO. A patient with suspected sarcoidosis died from miliary tuberculosis. Scand J Infect Dis 2000;32(2):218-220.
183. Sundhedsstyrelsen. Vejledning om forholdsregler ved optræden af tuberkulose. von Magnus M, Kaaber K, editors. 1505-1-1993, 3-14. 28-11-1996. København, Sundhedsstyrelsen. Ref Type: Report.
184. Kok-Jensen A. [When can tuberculosis be eradicated in Denmark?]. Ugeskr Laeger 1995;157(3):273-279.
185. van Burg JL, Verver S, Borgdorff MW. The epidemiology of tuberculosis among asylum seekers in The Netherlands: implications for screening. Int J Tuberc Lung Dis 2003;7(2):139-144.
186. Dahl R, Bæk K, Iversen M, Mygind N, Nielsen T, Taudorf E. Tuberkulose - en praktisk vejledning: Diagnostik, behandling og miljøundersøgelse. Den Almindelige Danske Lægeforening, editor. 12, 1-8. 2000. København, Dansk Lungemedicinsk Selskab.